Agilent Technologies, Inc. (A)

NYSE: A · Real-Time Price · USD

115.43

-1.21 (-1.04%)

At close: Mar 10, 2026, 4:00 PM EDT

115.75

+0.32 (0.28%)

Pre-market: Mar 11, 2026, 5:55 AM EDT

Revenue Breakdown

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Jul '25 Jul 31, 2025	Apr '25 Apr 30, 2025	Jan '25 Jan 31, 2025	Oct '24 Oct 31, 2024	Jul '24 Jul 31, 2024	Apr '24 Apr 30, 2024	Jan '24 Jan 31, 2024	Oct '23 Oct 31, 2023	Jul '23 Jul 31, 2023	Apr '23 Apr 30, 2023	Jan '23 Jan 31, 2023	Oct '22 Oct 31, 2022	Jul '22 Jul 31, 2022	Apr '22 Apr 30, 2022	Jan '22 Jan 31, 2022	Oct '21 Oct 31, 2021	Jul '21 Jul 31, 2021	Apr '21 Apr 30, 2021	Jan '21 Jan 31, 2021	Oct '20 Oct 31, 2020	Jul '20 Jul 31, 2020	Apr '20 Apr 30, 2020
Life Sciences & Diagnostics Markets Revenue	679.00M
Life Sciences & Diagnostics Markets Revenue Growth	4.95%
Agilent CrossLab Revenue (Post-FY2024 Reporting)	758.00M
Agilent CrossLab Revenue (Post-FY2024 Reporting) Growth	8.91%
Applied Markets Revenue	361.00M
Applied Markets Revenue Growth	6.80%
Revenue (Total)	1.80B
Revenue (Total) Growth	6.96%

EBIT

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Jul '25 Jul 31, 2025	Apr '25 Apr 30, 2025	Jan '25 Jan 31, 2025	Oct '24 Oct 31, 2024	Jul '24 Jul 31, 2024	Apr '24 Apr 30, 2024	Jan '24 Jan 31, 2024	Oct '23 Oct 31, 2023	Jul '23 Jul 31, 2023	Apr '23 Apr 30, 2023	Jan '23 Jan 31, 2023	Oct '22 Oct 31, 2022	Jul '22 Jul 31, 2022	Apr '22 Apr 30, 2022	Jan '22 Jan 31, 2022	Oct '21 Oct 31, 2021	Jul '21 Jul 31, 2021	Apr '21 Apr 30, 2021	Jan '21 Jan 31, 2021	Oct '20 Oct 31, 2020	Jul '20 Jul 31, 2020	Apr '20 Apr 30, 2020
Life Sciences & Diagnostics Markets Income from Operations	109.00M
Life Sciences & Diagnostics Markets Income from Operations Growth	-6.84%
Agilent CrossLab Income from Operations (Post-FY2024 Reporting)	240.00M
Agilent CrossLab Income from Operations (Post-FY2024 Reporting) Growth	8.60%
Applied Markets Income from Operations	93.00M
Applied Markets Income from Operations Growth	10.71%
Operating Income (Other)	-89.00M
Operating Income (Total)	353.00M
Operating Income (Total) Growth	-6.12%

Updated Jan 31, 2026. Data Source: Fiscal.ai.